Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+19.5%
5Y CAGR+46.4%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
+19.5%/yr
vs +57.9%/yr prior
5Y CAGR
+46.4%/yr
Recent deceleration
Acceleration
-38.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $183.24M | +83.9% |
| 2024 | $99.64M | +20.7% |
| 2023 | $82.55M | -23.2% |
| 2022 | $107.46M | +529.3% |
| 2021 | $17.07M | -37.4% |
| 2020 | $27.28M | -50.0% |
| 2019 | $54.55M | +215.2% |
| 2018 | $17.31M | +17.1% |
| 2017 | $14.78M | +184.9% |
| 2016 | $-17.41M | - |